BioSpace News Archive

Novamind Inc. is pleased to announce it has been selected by Mind Medicine, Inc. to host a phase IIb randomized clinical trial investigating lysergic acid diethylamide (LSD) for generalized anxiety disorder (GAD) in adults.

Ossium Health, Inc., a clinical-stage bioengineering company developing cellular therapeutics to revolutionize treatment of blood, immune, and inflammatory diseases, announced that the U.S. Food and Drug Administration has accepted its Investigational New Drug application for OSSM-001, a mesenchymal stem cell product, for the treatment of refractory perianal fistulas in patients with Crohn’s disease.

EdiGene, Inc. entered a non-exclusive, worldwide license agreement with Boston Children’s Hospital for intellectual property related to methods and compositions for increasing fetal hemoglobin levels by disrupting BCL11A expression at the genomic level to treat hemoglobinopathies.

Mentice, a world leader in simulation solutions for image-guided interventional therapies, announced today that Siemens Healthineers China via an official importation agent, has placed an order of ten (10) Mentice VIST simulator packages including the Siemens Virtual Patient Link software to be bundled with the Corindus CorPath GRX Robitic system sales in China.

Prothena Corporation plc presented new preclinical data from both its dual Aβ/tau vaccine for the potential treatment and prevention of Alzheimer’s disease and from its tandem C-terminal α-synuclein vaccine programs for the potential treatment and prevention of Parkinson’s disease and related synucleinopathies.

Boston Scientific Corporation announced that, pursuant to the previously announced cash tender offer for up to $2.5 billion aggregate principal amount of the outstanding senior notes identified in the table and the related notes below, $5,139,194,000 in aggregate principal amount of the Securities were validly tendered and not validly withdrawn on or prior to 5:00 p.m., Eastern Time, on March 15, 2022.

NuGen Medical Devices Inc., a leader in needle-free drug delivery, is pleased to announce that it has signed a 5-year distribution agreement with Harrington Consultants Limited and its joint venture partner Al Mufid Pharmaceuticals.

Spectral Medical Inc., announced that its wholly owned subsidiary, Dialco Medical Inc., has formed a Medical Advisory Board to support in guiding the DIMI usability trial and continued development of the DIMI device.

Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, announced data from a Pooled-Analysis of Studies LBS-IST-POI-101 and LBS-POI-201-CN (PROFILE-CN.)

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced final findings from a randomized, international, multi-center study that confirmed the effectiveness of the GI Genius™ intelligent endoscopy module, which uses AI as an aid in detecting colorectal polyps during colonoscopy, potentially helping to prevent colorectal cancer (CRC).